In my humble opinion, should Sth Africa trials go very well, VHL should go license this with a big Pharma asap, I dont agree with them "seeking non-dilutive funding for PhaseII in the USA prior to seeking licensing after those trials"... the clock on patent expiry is always ticking and given VHL's meagre funds, they need to give it to the big boys & let them run with it...
price rampers, page-4
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)